Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 56 | ECE2018 | Next issue

20th European Congress of Endocrinology

Barcelona, Spain
19 May 2018 - 22 May 2018

Card image cap
ECE 2018, 19 - 22 May 2018; Barcelona, Spain

Poster Presentations: Interdisciplinary Endocrinology

Cardiovascular Endocrinology and Lipid Metabolism

ea0056p624 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2018

Impact of the metabolic syndrome on the renal function after partial nephrectomy for nonmetastatic localized renal cell carcinoma

Chaker Kays , Sellami Ahmed , Ouanes Yassine , Chehida Mohamed Ali Ben , Essid Mohamed Ali , Bibi Mokhtar , Abid Karem , Rhouma Sami Ben , Nouira Yassine

Introduction and objectives: The most important risk factors of chronic kidney disease (CKD) are diabetes and hypertension. In addition, obesity and metabolic syndrome (MetS) are independent predictive factors of CKD. The objective of our study was to investigate if MetS affects renal function of patients who underwent partial nephrectomy for localized renal cell carcinoma (RCC).Patients and methods: 50 cases of T1N0M0 RCC patients who underwent partial ...

ea0056p625 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2018

Is SFRP-4 an early potential biomarker related to diabetes and hypertension, in patients with androgenic alopecia?

Ipekci Suleyman , Sozen Mehmet , Abusoglu Sedat , Baldane Suleyman , Akyurek Fatma , Kirac Cem Onur , Kebapcilar Ayse Gul , Unlu Ali , Kebapcilar Levent

Androgenic alopecia (AGA) is an important clinical issue that can cause significant cosmetic problems. Many factors such as genetic, androgen hormones, environmental factors, and inflammation are involved in the pathogenesis of androgenic alopecia. Insulin and insulin resistance have been found increased in individuals with AGA. There are many proinflammatory substances which are playing role in the pathogenesis of androgenic alopecia. Secreted frizzled related protein-4 (SFRP...

ea0056p626 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2018

Multi-hormonal deficits in heart failure with preserved ejection Fraction: prevalence and impact on diastolic dysfunction

Bruno Carmine , Favuzzi Angela Maria Rita , Vergani Edoardo , Venuti Angela , Nicolazzi Maria Anna , Fuorlo Mariella , Landolfi Raffaele , Mancini Antonio

Background: In heart failure with reduced ejection fraction (HFrEF), catabolic mechanisms have a strong negative impact on morbidity and mortality. The relationship between anabolic hormonal deficit, thyroid function and heart failure with preserved ejection fraction (HFpEF) has still been poorly investigated. For this reason, we tried to define the prevalence of multi-hormonal deficiencies in HFpEF patients and the relationships between hormonal deficits and echocardiographic...

ea0056p627 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2018

Cross-hormone treatment: review of cardiovascular risk factors and bone mineral density in 25 transsexual subjects followed in a tertiary hospital

Azkutia Ane , Herraiz Lorea , Jimenez Ines , Barrio Elvira , Ramos Elvira , Cuesta Martin , Diaz Angel

Introduction and objectives: Transsexuality refers to discrepancy between the assigned sex/gender at birth and the one that the subject identifies with. The use of the cross hormone treatment as sex/gender change method implies the necessity of monitorize the hormone levels and potential treatment risks. Our study tries to evaluate the relationship between the hormone changes and the changes in the cardiovascular risk factors and the bone mineral density.<p class="abstext"...

ea0056p628 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2018

How the diagnose of the dilatation of ascending aorta in Turner syndrome can be verified?

Kriksciuniene Ruta , Zaikauskas Mindaugas , Lukosevicius Saulius , Zilaitiene Birute , Verkauskiene Rasa

Introduction: Two major strategies can be used to verify the diagnosis of ascending aortic dilatation in Turner syndrome (TS): the diameter of the aorta adjusted for body surface area (BSA) can be estimated or the ratio of the ascending/descending aorta may be assessed.Aim: To identify the difference of the prevalence of ascending aortic dilatation in patients with Turner syndrome by measuring the diameter of the ascending aorta adjusted for BSA and by e...

ea0056p629 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2018

Fibroblast growth factor-21 predicts adverse outcome in community-acquired pneumonia

Ebrahimi Fahim , Wolffenbuttel Carole , Blum Claudine A , Muller Beat , Schuetz Philipp , Christ-Crain Mirjam , Betz Matthias Johannes

Introduction: Fibroblast growth factor-21 (FGF-21) is a recently discovered hormone acting as a central regulator of metabolism via adaptation of glucose homeostasis, insulin sensitivity, and ketogenesis. While acute systemic inflammatory conditions come along with profound alterations of metabolism, the role of FGF-21 in these acute phase responses is still unknown.Methods: This is a secondary analysis of two randomized, controlled trials in patients pr...